LONDON (Alliance News) - Imperial Innovations Group PLC Monday said it had committed GBP4.5 million to a GBP20 million funding round launched by MISSION Therapeutics, one of its portfolio companies.
It said the new financing will allow Mission to advance its cancer treatment programmes.
Imperial Innovations last traded at 412.5 pence.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright © 2013 Alliance News Limited. All Rights Reserved.